T L Towers
Overview
Explore the profile of T L Towers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
1502
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Samuelsson A, Towers T, Ravetch J
Science
. 2001 Feb;
291(5503):484-6.
PMID: 11161202
The molecular basis for the anti-inflammatory property of intravenous gamma globulin (IVIG) was investigated in a murine model of immune thrombocytopenia. Administration of clinically protective doses of intact antibody or...
2.
Clynes R, Towers T, Presta L, Ravetch J
Nat Med
. 2000 Mar;
6(4):443-6.
PMID: 10742152
Inhibitory receptors have been proposed to modulate the in vivo cytotoxic response against tumor targets for both spontaneous and antibody-dependent pathways. Using a variety of syngenic and xenograft models, we...
3.
Towers T, Staeva T, Freedman L
Mol Cell Biol
. 1999 May;
19(6):4191-9.
PMID: 10330159
We previously described a control element in the granulocyte-macrophage colony-stimulating factor (GM-CSF) enhancer that is necessary and sufficient to mediate both transcriptional activation in response to T-cell stimuli and transcriptional...
4.
Towers T, Freedman L
J Biol Chem
. 1998 May;
273(17):10338-48.
PMID: 9553089
The primary function of activated T lymphocytes is to produce various cytokines necessary to elicit an immune response; these cytokines include interleukin-2 (IL-2), interleukin-4, and granulocyte-macrophage colony-stimulating factor (GMCSF). Steroid...
5.
Alroy I, Towers T, Freedman L
Mol Cell Biol
. 1995 Oct;
15(10):5789-99.
PMID: 7565732
T-lymphocyte proliferation is suppressed by 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], the active metabolite of vitamin D3, and is associated with a decrease in interleukin 2 (IL-2), gamma interferon, and granulocyte-macrophage colony-stimulating factor...
6.
Towers T, Luisi B, Asianov A, Freedman L
Proc Natl Acad Sci U S A
. 1993 Jul;
90(13):6310-4.
PMID: 8392196
The 1,25-dihydroxyvitamin D3 receptor, like other members of the nuclear receptor superfamily, forms dimers in solution that are probably stabilized by a dyad symmetrical interface formed by the ligand-binding domain....
7.
Freedman L, Towers T
Mol Endocrinol
. 1991 Dec;
5(12):1815-26.
PMID: 1665202
The DNA binding domains of the nuclear receptor superfamily are highly conserved and consist of residues that fold into two zinc finger-like motifs, suggesting that the structures of this region...